FDA “Misrepresented” Ephedra Dosing With Use Of Old Label In Court – Emord
This article was originally published in The Tan Sheet
Executive Summary
FDA lawyers misrepresented product labeling for Nutraceutical Corporation's ephedra dietary supplements to a Utah appeals court by referencing a discontinued label that instructed consumers to take high doses of the product, according to law firm Emord & Associates